Westamerica Ban (WABC)
(Delayed Data from NSDQ)
$51.79 USD
+0.27 (0.52%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $51.80 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth B Momentum D VGM
Income Statements
Fiscal Year end for Westamerica Bancorporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 328 | 267 | 217 | 211 | 206 |
Cost Of Goods | 4 | 2 | 2 | 2 | 2 |
Gross Profit | 324 | 265 | 215 | 210 | 204 |
Selling & Adminstrative & Depr. & Amort Expenses | 102 | 99 | 98 | 103 | 99 |
Income After Depreciation & Amortization | 222 | 166 | 117 | 107 | 105 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 222 | 166 | 117 | 107 | 105 |
Income Taxes | 60 | 44 | 31 | 26 | 25 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 162 | 122 | 87 | 80 | 80 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 162 | 122 | 87 | 80 | 80 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 233 | 181 | 128 | 125 | 126 |
Depreciation & Amortization (Cash Flow) | 11 | 15 | 11 | 18 | 20 |
Income After Depreciation & Amortization | 222 | 166 | 117 | 107 | 105 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 26.71 | 26.91 | 26.87 | 26.96 | 27.01 |
Diluted EPS Before Non-Recurring Items | 6.06 | 4.54 | 3.22 | 2.83 | 2.98 |
Diluted Net EPS (GAAP) | 6.06 | 4.54 | 3.22 | 2.98 | 2.98 |
Fiscal Year end for Westamerica Bancorporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 79.57 | 78.84 | 82.04 | 84.13 | 81.19 |
Cost Of Goods | 2.46 | 2.11 | 1.64 | 1.10 | 0.58 |
Gross Profit | 77.11 | 76.74 | 80.41 | 83.03 | 80.61 |
SG&A, R&D, and Dept/Amort Expenses | 26.13 | 26.40 | 25.52 | 26.05 | 25.84 |
Income After SG&A, R&D, and Dept/Amort Expenses | 50.98 | 50.34 | 54.89 | 56.98 | 54.77 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 2.85 | 0.90 | 0.04 | 0.04 | 0.03 |
Pretax Income | 48.14 | 49.44 | 54.85 | 56.95 | 54.74 |
Income Taxes | 12.67 | 13.03 | 15.38 | 15.35 | 14.50 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 35.46 | 36.42 | 39.47 | 41.60 | 40.25 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 35.46 | 36.42 | 39.47 | 41.60 | 40.25 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 26.68 | 26.68 | 26.66 | 26.65 | 26.65 |
Diluted EPS Before Non-Recurring Items | 1.33 | 1.37 | 1.48 | 1.55 | 1.51 |
Diluted Net EPS (GAAP) | 1.33 | 1.37 | 1.48 | 1.56 | 1.51 |